Pharmaceuticals: Tailor-made meds
The regulation of all medicinal products is based on risk management. It is an accepted principle that no medicinal product is entirely without risk - the use and regulation of medicines is therefore calibrated on the concept of benefit versus risk; that is, the degree to which the benefit that the product brings to the patient outweighs the risk to the health of the patient.
Personalised medicine means doctors could soon be prescribing drugs tailored to individuals’ genes. Simmons’ Jacques-Antoine Robert discusses the challenges facing watchdogs and lawyers addressing this brave new world
This premium content is reserved for
Legal Week Subscribers.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651